Flublok Quadrivalent FDA Approval History
Last updated by Judith Stewart, BPharm on Oct 28, 2020.
FDA Approved: Yes (First approved October 7, 2016)
Brand name: Flublok Quadrivalent
Generic name: influenza virus vaccine, inactivated
Dosage form: Injection
Company: Protein Sciences Corp.
Treatment for: Influenza Prophylaxis
Flublok Quadrivalent is an influenza virus vaccine indicated for active immunization against seasonal influenza in adults 18 years of age and older .
Development timeline for Flublok Quadrivalent
| Date | Article |
|---|---|
| Oct 11, 2016 | Approval FDA Approves Flublok Quadrivalent Influenza Vaccine |
| Jun 23, 2016 | Approval FDA Approved Longer Shelf Life for the Game Changer, Flublok Influenza Vaccine |
| Oct 29, 2014 | Approval Flublok Influenza Vaccine Now Approved for Adults Ages 18 and Older |
| Jan 16, 2013 | Approval FDA Approves Flublok - New Seasonal Influenza Vaccine Made Using Novel Technology |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
